Uronium / guanidinium reagents represent 38.7% of reagent type sales and solid phase peptide synthesis accounts for 64.3% within the synthesis method segment in 2026. The peptide coupling reagents market is estimated at USD 1.2 billion in 2026 and is forecast to post an 8.9% CAGR between 2026 and 2036.